Dana-Farber Cancer Institute Researchers Join Global Cancer Grand Challenges Team Taking on Solid Tumors in Children
Physician Survey Shows Lack of Understanding of the FDA’s Approval Process
Fox Chase Fellows – Winter 2024
Many Legacies to Carry On
Laurie H. Glimcher, MD, Selected for STAT's 2024 STATUS List
Dana-Farber Researchers Receive AACR 2024 Scientific Achievement Awards
Dana-Farber CEO Laurie Glimcher Has Always Been a Trail-Blazer and a Risk-Taker
Antibody-Drug Conjugates: A Cancer Therapy Revolution
Preserving Laryngeal Structure and Function for Patients with Cancer
How to Improve Survival for Pediatric Leukemia Patients
Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer
Roswell Park Comprehensive Cancer Center, Generate:Biomedicines Enter Into Collaboration Agreement to Accelerate Novel Cell Therapies For Oncology Using Generative AI
Inspiring Residents to Climb Higher
Cedars-Sinai Cancer Releases 2024 Annual Report
Immunotherapy for Cancer: What it Is, How it Works, and Where it’s Going
Showing 76 - 90 of 1027 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...69 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
